{"id":"dhea-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Acne"},{"rate":null,"effect":"Hirsutism"},{"rate":null,"effect":"Androgenic effects"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Insomnia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"DHEA is a naturally occurring C19 steroid produced by the adrenal glands and gonads. It serves as a precursor for testosterone and estrogen synthesis and is thought to enhance immune function, reduce inflammation, and improve metabolic parameters. The therapeutic rationale involves restoring age-related declines in DHEA levels to improve various physiological functions.","oneSentence":"DHEA (dehydroepiandrosterone) is an endogenous steroid hormone precursor that acts as a substrate for the synthesis of androgens and estrogens, modulating hormonal balance and immune function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:44:20.229Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Age-related DHEA deficiency"},{"name":"Systemic lupus erythematosus (SLE)"}]},"trialDetails":[{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT07407647","phase":"PHASE2","title":"Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-03-01","conditions":"Anal Carcinoma, Cervical Carcinoma, Malignant Female Reproductive System Neoplasm","enrollment":25},{"nctId":"NCT04488757","phase":"NA","title":"Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2021-11-04","conditions":"Chronic Widespread Pain, Stress, Psychological, Stress, Physiological","enrollment":70},{"nctId":"NCT03648385","phase":"PHASE2","title":"Effects of DHEA in Pulmonary Hypertension","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2019-01-09","conditions":"Pulmonary Arterial Hypertension","enrollment":26},{"nctId":"NCT03228732","phase":"EARLY_PHASE1","title":"The Effects of Fluoxetine and/or DHEA","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-19","conditions":"Type 1 Diabetes Mellitus","enrollment":60},{"nctId":"NCT05562518","phase":"PHASE4","title":"GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2022-03-21","conditions":"Vulvovaginal Atrophy, Breast Cancer","enrollment":160},{"nctId":"NCT05623059","phase":"PHASE1, PHASE2","title":"Evaluate Pharmacokinetics and Safety of Slow Release DHEA","status":"COMPLETED","sponsor":"Indiana University","startDate":"2023-03-03","conditions":"Asthma, Genotype","enrollment":18},{"nctId":"NCT06472765","phase":"","title":"Vaginal Ecosystem and Network in the United States Study","status":"ENROLLING_BY_INVITATION","sponsor":"Vaginal Biome Science","startDate":"2024-05-16","conditions":"Bacterial Vaginosis, Candidiasis, Urinary Tract Infections","enrollment":3250},{"nctId":"NCT02357472","phase":"NA","title":"The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor Responders","status":"TERMINATED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2014-01-01","conditions":"Infertility","enrollment":60},{"nctId":"NCT04375657","phase":"PHASE2","title":"Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial","status":"RECRUITING","sponsor":"Intervene Immune, Inc.","startDate":"2020-11-23","conditions":"Epigenetic Aging, Immunosenescence","enrollment":85},{"nctId":"NCT05692960","phase":"NA","title":"Women's Interventions for Sexual Health: WISH","status":"COMPLETED","sponsor":"The University of Tennessee, Knoxville","startDate":"2023-02-15","conditions":"Sexual Dysfunction, Physiological, Body Image, Libido; Loss, Aversion","enrollment":30},{"nctId":"NCT03227458","phase":"NA","title":"DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-02-12","conditions":"Low Bone Mass, Osteoporosis, Postmenopausal","enrollment":152},{"nctId":"NCT04493333","phase":"PHASE2","title":"Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2021-06-07","conditions":"Vaginal Atrophy, Postmenopausal Symptoms, Breast Cancer Female","enrollment":8},{"nctId":"NCT06611514","phase":"PHASE3","title":"Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"European Institute of Oncology","startDate":"2024-12-01","conditions":"Women With Breast Cancer","enrollment":95},{"nctId":"NCT04982692","phase":"PHASE3","title":"A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2021-09-13","conditions":"Postmenopausal Vulvovaginal Atrophy","enrollment":417},{"nctId":"NCT03383133","phase":"EARLY_PHASE1","title":"Studies of Sulfur Metabolism in Humans","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-01-11","conditions":"Metabolic Side Effects of Drugs","enrollment":1},{"nctId":"NCT05434351","phase":"","title":"The Outcome of Chinese Women With Genitourinary Syndrome of Menopause Treated With Vaginal Dehydroepiandrosterone","status":"TERMINATED","sponsor":"Chinese University of Hong Kong","startDate":"2022-08-01","conditions":"Genitourinary Syndrome of Menopause","enrollment":4},{"nctId":"NCT05903716","phase":"","title":"The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris","status":"UNKNOWN","sponsor":"Marmara University","startDate":"2022-09-15","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT05856604","phase":"NA","title":"Music Therapy for Older Adults With Cognitive Decline Living in Care Homes","status":"COMPLETED","sponsor":"Middlesex University","startDate":"2018-02-01","conditions":"Cognitive Impairment, Cognitive Decline","enrollment":42},{"nctId":"NCT03491007","phase":"PHASE2","title":"Neurosteroids in PTSD - Biomarkers to Therapeutics","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-07-08","conditions":"Posttraumatic Stress Disorder","enrollment":5},{"nctId":"NCT03568604","phase":"PHASE4","title":"Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia","status":"COMPLETED","sponsor":"San Diego Sexual Medicine","startDate":"2018-08-07","conditions":"Dyspareunia","enrollment":18},{"nctId":"NCT04705883","phase":"PHASE4","title":"Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2020-09-01","conditions":"Vulvar Atrophy, Breast Cancer, Genitourinary Syndrome of Menopause","enrollment":10},{"nctId":"NCT01273259","phase":"PHASE2","title":"Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2008-05-06","conditions":"Chronic Obstructive Pulmonary Disease, Hypertension, Pulmonary","enrollment":51},{"nctId":"NCT04898556","phase":"PHASE3","title":"Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain","status":"UNKNOWN","sponsor":"Dr. Santiago Palacios","startDate":"2020-12-22","conditions":"Vulvovaginal Atrophy","enrollment":50},{"nctId":"NCT03287232","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2017-10-16","conditions":"Hypoactive Sexual Desire Disorder","enrollment":653},{"nctId":"NCT01662466","phase":"PHASE1, PHASE2","title":"Effect of Testosterone Treatment on Embryo Quality","status":"UNKNOWN","sponsor":"Center for Human Reproduction","startDate":"2012-07-01","conditions":"Primary Ovarian Insufficiency, Female Infertility Due to Diminished Ovarian Reserve","enrollment":180},{"nctId":"NCT03740945","phase":"PHASE3","title":"Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-06","conditions":"Vaginal Atrophy in Breast Cancer Patients","enrollment":""},{"nctId":"NCT03619005","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-13","conditions":"Hypoactive Sexual Desire Disorder (HSDD)","enrollment":""},{"nctId":"NCT04355663","phase":"NA","title":"Neuroproprioceptive \"Facilitation, Inhibition\" and Brain Plasticity","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2015-05-20","conditions":"Multiple Sclerosis","enrollment":92},{"nctId":"NCT04379193","phase":"NA","title":"Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Serum Level of Neuroactive Steroids","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2015-05-20","conditions":"Multiple Sclerosis","enrollment":63},{"nctId":"NCT00972023","phase":"PHASE1","title":"DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer","status":"TERMINATED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2010-02","conditions":"Breast Cancer","enrollment":1},{"nctId":"NCT00607646","phase":"EARLY_PHASE1","title":"Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2010-10","conditions":"Type 1 Diabetes","enrollment":50},{"nctId":"NCT03967964","phase":"PHASE1","title":"Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2015-11-20","conditions":"Pharmacokinetics, Hormone Deficiency","enrollment":46},{"nctId":"NCT02268032","phase":"PHASE1","title":"Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2014-07-15","conditions":"Healthy Women, Infertility, Female","enrollment":94},{"nctId":"NCT01376349","phase":"PHASE3","title":"Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2011-07","conditions":"Breast Cancer, Gynecologic Cancer","enrollment":464},{"nctId":"NCT03782480","phase":"PHASE3","title":"Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy","status":"UNKNOWN","sponsor":"Center for Vulvovaginal Disorders","startDate":"2019-03-02","conditions":"Menopause, Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy","enrollment":40},{"nctId":"NCT03783988","phase":"PHASE1","title":"Study With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to Glucocorticoids","status":"UNKNOWN","sponsor":"Trophea Development AB","startDate":"2019-01-15","conditions":"Skin Atrophy","enrollment":10},{"nctId":"NCT03621683","phase":"NA","title":"Antioxidants vs. Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve","status":"COMPLETED","sponsor":"Lucy Coleman","startDate":"2016-01-06","conditions":"Ovarian Reserve","enrollment":78},{"nctId":"NCT01535872","phase":"PHASE3","title":"Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients","status":"COMPLETED","sponsor":"KK Women's and Children's Hospital","startDate":"2012-02","conditions":"Infertility, Poor Responder to IVF Treatment","enrollment":60},{"nctId":"NCT00310791","phase":"PHASE2, PHASE3","title":"Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2004-04","conditions":"Anorexia Nervosa","enrollment":80},{"nctId":"NCT02794948","phase":"PHASE1, PHASE2","title":"Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency","status":"COMPLETED","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2016-04","conditions":"Primary Ovarian Insufficiency","enrollment":48},{"nctId":"NCT02766764","phase":"PHASE4","title":"Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-06","conditions":"Subfertility","enrollment":230},{"nctId":"NCT01724242","phase":"PHASE2, PHASE3","title":"Vaginal DHEA for Women After Breast Cancer","status":"WITHDRAWN","sponsor":"Hadassah Medical Organization","startDate":"2013-02","conditions":"Vaginal Dryness, Breast Cancer, Urinary Incontinence","enrollment":""},{"nctId":"NCT02549690","phase":"NA","title":"Testosterone Gel in Poor Responders Undergoing IVF","status":"WITHDRAWN","sponsor":"Vietnam National University","startDate":"2015-09","conditions":"Infertility","enrollment":""},{"nctId":"NCT00429806","phase":"PHASE1","title":"DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2006-11","conditions":"Vaginal Atrophy","enrollment":40},{"nctId":"NCT02229604","phase":"PHASE1","title":"Electroacupuncture for Diminished Ovarian Reserve","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2014-01","conditions":"Irregular Menses","enrollment":57},{"nctId":"NCT02000375","phase":"PHASE2","title":"A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)","status":"TERMINATED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2013-03","conditions":"Metastatic Breastcancer, Estrogen Receptor Positive Breast Cancer, Estrogen Receptor Negative Neoplasm","enrollment":20},{"nctId":"NCT00516698","phase":"","title":"Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2007-09","conditions":"Breast Cancer","enrollment":140},{"nctId":"NCT00289926","phase":"PHASE3","title":"Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms","status":"COMPLETED","sponsor":"Monash University","startDate":"2006-02","conditions":"Quality of Life, Menopausal Syndrome, Libido Disorder","enrollment":240},{"nctId":"NCT01572025","phase":"PHASE3","title":"Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2012-05","conditions":"Infertility, Ovarian Aging, Diminished Ovarian Reserve (DOR)","enrollment":60},{"nctId":"NCT01861847","phase":"PHASE2","title":"7-Keto DHEA for the Treatment of PTSD","status":"COMPLETED","sponsor":"Humanetics Corporation","startDate":"2013-02","conditions":"PTSD","enrollment":71},{"nctId":"NCT00650754","phase":"PHASE2, PHASE3","title":"Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility","status":"TERMINATED","sponsor":"Center for Human Reproduction","startDate":"2008-03","conditions":"Primary Ovarian Insufficiency, Unexplained Infertility","enrollment":35},{"nctId":"NCT00581087","phase":"PHASE3","title":"Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2007-01","conditions":"Chronic Obstructive Pulmonary Disease, Hypertension, Pulmonary","enrollment":60},{"nctId":"NCT00566384","phase":"PHASE2","title":"Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-11","conditions":"Libido","enrollment":100},{"nctId":"NCT02099916","phase":"PHASE2, PHASE3","title":"Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF","status":"UNKNOWN","sponsor":"University of Athens","startDate":"2014-10","conditions":"Efficacy of DHEA, Pregnancy Rate, Diminished Ovarian Reserve","enrollment":50},{"nctId":"NCT02132559","phase":"","title":"Effect of Dehydroepiandrosterone Administration in Patients With Poor Ovarian Response According to the Bologna Criteria","status":"COMPLETED","sponsor":"Chinese Medical Association","startDate":"2011-10","conditions":"Infertility","enrollment":386},{"nctId":"NCT01915186","phase":"NA","title":"Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2010-10","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":104},{"nctId":"NCT01452373","phase":"PHASE3","title":"Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2011-10","conditions":"Vasomotor Symptoms, Hot Flushes","enrollment":238},{"nctId":"NCT01753037","phase":"NA","title":"Effects of Androgen Administration on Inflammation in Normal Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-12","conditions":"Hyperandrogenism","enrollment":25},{"nctId":"NCT00900900","phase":"PHASE2","title":"The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers","status":"COMPLETED","sponsor":"Jed E. Rose","startDate":"2009-07","conditions":"Substance Withdrawal Syndrome","enrollment":22},{"nctId":"NCT00948857","phase":"PHASE2, PHASE3","title":"Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)","status":"TERMINATED","sponsor":"David H. Barad","startDate":"2009-06","conditions":"Premature Ovarian Failure","enrollment":5},{"nctId":"NCT00516542","phase":"PHASE1","title":"Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2007-06","conditions":"Breast Cancer","enrollment":6},{"nctId":"NCT00376818","phase":"NA","title":"Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2006-06","conditions":"Brain and Central Nervous System Tumors, Psychosocial Effects of Cancer and Its Treatment","enrollment":4},{"nctId":"NCT00006219","phase":"PHASE2","title":"Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2000-08","conditions":"Multiple Myeloma and Plasma Cell Neoplasm","enrollment":""},{"nctId":"NCT01145144","phase":"NA","title":"Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment","status":"COMPLETED","sponsor":"Meir Medical Center","startDate":"2008-01","conditions":"Ovarian Stimulation","enrollment":""},{"nctId":"NCT00916396","phase":"NA","title":"Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2005-06","conditions":"Hypoactive Sexual Desire Disorder","enrollment":50},{"nctId":"NCT00332670","phase":"PHASE2, PHASE3","title":"Light Therapy for Elderly Depression","status":"TERMINATED","sponsor":"GGZ Buitenamstel","startDate":"2003-01","conditions":"Major Depressive Disorder","enrollment":89},{"nctId":"NCT00664053","phase":"PHASE4","title":"Effects of DHEA/Exercise on Bone, Muscle and Balance","status":"COMPLETED","sponsor":"National Aeronautics and Space Administration (NASA)","startDate":"2004-10","conditions":"Osteoporosis, Frailty","enrollment":99},{"nctId":"NCT00419913","phase":"PHASE2, PHASE3","title":"A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)","status":"TERMINATED","sponsor":"Center for Human Reproduction","startDate":"2007-01","conditions":"Infertility, Decreased Ovarian Reserve","enrollment":8},{"nctId":"NCT00001598","phase":"PHASE2","title":"DHEA Treatment for Sjogren's Syndrome","status":"COMPLETED","sponsor":"National Institute of Dental and Craniofacial Research (NIDCR)","startDate":"1997-05","conditions":"Lacrimal Apparatus Disease, Salivary Gland Disease, Sjogren's Syndrome","enrollment":28},{"nctId":"NCT00001487","phase":"PHASE2","title":"Treatment of Mid-Life-Related Mood Disorders","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1995-06","conditions":"Depressive Disorder, Mood Disorder","enrollment":60},{"nctId":"NCT00082511","phase":"PHASE3","title":"GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids","status":"COMPLETED","sponsor":"Genelabs Technologies","startDate":"2003-07","conditions":"Systemic Lupus Erythematosus","enrollment":114},{"nctId":"NCT00053560","phase":"PHASE3","title":"To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids","status":"UNKNOWN","sponsor":"Genelabs Technologies","startDate":"2002-12","conditions":"Lupus","enrollment":155},{"nctId":"NCT00543166","phase":"PHASE4","title":"Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue","status":"UNKNOWN","sponsor":"University of Helsinki","startDate":"2003-02","conditions":"Sjogren's Syndrome","enrollment":107},{"nctId":"NCT00549081","phase":"NA","title":"DHEA Supplementation for Low Ovarian Response IVF Patients","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2008-01","conditions":"Infertility, Female, In-Vitro Fertilization","enrollment":""},{"nctId":"NCT00106314","phase":"PHASE2","title":"An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease","status":"COMPLETED","sponsor":"Inflabloc Pharmaceuticals","startDate":"2005-01","conditions":"Crohn's Disease","enrollment":75},{"nctId":"NCT00471900","phase":"NA","title":"Six Months DHEA Treatment in Female Adrenal Failure","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2001-10","conditions":"Adrenal Insufficiency","enrollment":10},{"nctId":"NCT00442403","phase":"PHASE3","title":"Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria","status":"SUSPENDED","sponsor":"Université Victor Segalen Bordeaux 2","startDate":"2002-04","conditions":"Malaria","enrollment":200},{"nctId":"NCT00391924","phase":"PHASE2","title":"Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2000-05","conditions":"Lupus Erythematosus, Systemic, Sjogren's Syndrome","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"DHEA treatment","genericName":"DHEA treatment","companyName":"University Hospital, Bordeaux","companyId":"university-hospital-bordeaux","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DHEA (dehydroepiandrosterone) is an endogenous steroid hormone precursor that acts as a substrate for the synthesis of androgens and estrogens, modulating hormonal balance and immune function. Used for Age-related DHEA deficiency, Systemic lupus erythematosus (SLE).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}